- Vascular Overviews Group/Renal Studies Group
Lisa is a Statistical Programmer at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). She completed her degree in Applied Statistics at the University of Plymouth, and is now the statistical programming lead for the ATT (Anti-Thrombotic Trialists’ Collaboration), CTT (Cholesterol Treatment Trialists’ Collaboration) and STT (Stroke Thrombolysis Trialists’ Collaboration) projects within the CTSU’s Vascular Overviews Group. Her research interests focus on cardiovascular disease and large-scale individual participant meta-analyses of randomised studies.
Interpretation of the evidence for the efficacy and safety of statin therapy.
Collins R. et al, (2016), Lancet, 388, 2532 - 2561
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.
Lees KR. et al, (2016), Stroke, 47, 2373 - 2379
What are the risks of intracerebral haemorrhage due to alteplase after acute ischaemic stroke? Results from an individual patient data meta-analysis of randomised trials
Emberson J. and baigent None., (2016), Lancet Neurology
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
Herrington W. et al, (2016), The Lancet Diabetes and Endocrinology
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
(2016), American Heart Journal, 176, 63 - 69